# Bacterial Biofilms in Reconstructive Breast Prostheses Following Mastectomy

> **NCT03213249** · PHASE1 · COMPLETED · sponsor: **Washington University School of Medicine** · enrollment: 19 (actual)

## Conditions studied

- Breast Implant Infection
- Mammoplasty

## Interventions

- **OTHER:** Normal saline
- **DRUG:** Cefazolin
- **PROCEDURE:** Skin biopsy
- **PROCEDURE:** Bilateral skin- or nipple-sparing mastectomies
- **DEVICE:** Tissue expander
- **DEVICE:** Breast implant
- **PROCEDURE:** Autologous flap
- **OTHER:** Acellular dermal matrix sling
- **DRUG:** Gentamicin
- **DRUG:** Bacitracin

## Key facts

- **NCT ID:** NCT03213249
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-07-25
- **Primary completion:** 2018-09-26
- **Final completion:** 2018-09-26
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2019-02-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03213249

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03213249, "Bacterial Biofilms in Reconstructive Breast Prostheses Following Mastectomy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03213249. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*